Clinical Trials Logo

Clinical Trial Summary

This study will evaluate the safety, tolerability and efficacy of a single dose level of KB003 in subjects with inadequately controlled asthma.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01603277
Study type Interventional
Source KaloBios Pharmaceuticals
Contact
Status Completed
Phase Phase 2
Start date July 2012
Completion date January 2014